NDATOPICALDISC
Lifecycle
Pre-Launch
Clinical Trials
19
Data completeness
3/8 — Basic
DIPROSONE (betamethasone dipropionate) by Merck & Co. is [see ] . Approved for psoriasis, atopic dermatitis, chronic rhinosinusitis and 1 more indications.
Drug data last refreshed 2w ago
Mechanism of Action
[see ] . Betamethasone dipropionate is a corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action for the treatment of tinea pedis, tinea cruris and tinea corporis is unknown.
Worked on DIPROSONE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.